|
Acupuncture: More than Pain Management
A review of the research and potential of an ancient therapy in modern times It is now widely accepted across health care disciplines throughout the world that acupuncture can be effective in treating such painful conditions as migraine headaches, and low back, neck and knee pain, as well as a range of painful musculoskeletal conditions. Less well known is some of the promising research showing that this ancient form of treatment can be valuable in treating such diverse conditions as infertility, depression and allergic rhinitis (hay fever) — to name a few. Download Full White Paper (PDF) For a voluntary donation, you can download a high-resolution copy of the white paper that is suitable for printing and distribution. Learn More |
Acupuncture in Pain Management: Strengths and Weaknesses of a Promising Non-Pharmacologic Therapy in the Age of the Opioid Epidemic.
FDA Position Paper
(Download Full Paper PDF) (Cover Letter PDF)
FDA Position Paper
(Download Full Paper PDF) (Cover Letter PDF)
Acupuncture’s Role in Solving the Opioid Epidemic:
Evidence, Cost-Effectiveness, and Care Availability for Acupuncture as a Primary, Non-Pharmacologic Method for Pain Relief and Management
Written as part of a joint effort between The American Society of Acupuncturists (ASA), The American Alliance for Professional Acupuncture Safety (AAPAS), The Acupuncture Now Foundation (ANF), The American TCM Association (ATCMA), The American TCM Society (ATCMS), and National Federation of TCM Organizations (NFTCMO).
Originally written as our comments to the U.S. Food and Drug Administration (FDA) as they were re-writing their pain management guidelines in response to the North American opioid crisis. This paper calls for an expansion of acupuncture services in response to the opioid crisis. It reviews the most current research, highlights four milestone studies, addresses the criticism that acupuncture is only a placebo by reviewing the ethics inherent in considerations of the benefit to harm ratio, and discusses workforce and cost considerations that will need to be addressed with an expansion of acupuncture’s role in mainstream healthcare. A copy of our cover letter to the FDA is also found below.
Download Full Paper (PDF)
Evidence, Cost-Effectiveness, and Care Availability for Acupuncture as a Primary, Non-Pharmacologic Method for Pain Relief and Management
Written as part of a joint effort between The American Society of Acupuncturists (ASA), The American Alliance for Professional Acupuncture Safety (AAPAS), The Acupuncture Now Foundation (ANF), The American TCM Association (ATCMA), The American TCM Society (ATCMS), and National Federation of TCM Organizations (NFTCMO).
Originally written as our comments to the U.S. Food and Drug Administration (FDA) as they were re-writing their pain management guidelines in response to the North American opioid crisis. This paper calls for an expansion of acupuncture services in response to the opioid crisis. It reviews the most current research, highlights four milestone studies, addresses the criticism that acupuncture is only a placebo by reviewing the ethics inherent in considerations of the benefit to harm ratio, and discusses workforce and cost considerations that will need to be addressed with an expansion of acupuncture’s role in mainstream healthcare. A copy of our cover letter to the FDA is also found below.
Download Full Paper (PDF)
